Home
Groups
Pages
Marketplace
See More
Groups Pages Marketplace Events Blogs Funding Offers Courses
Sign In Sign Up
Night Mode
Multiple Sclerosis Drugs Market to Reach USD 39.7 Billion by 2036, Driven by Rising MS Prevalence and Growing Adoption of High-Efficacy Disease-Modifying Therapies
Multiple Sclerosis Drugs Market Overview Multiple sclerosis (MS) drugs are therapeutic agents used to manage multiple sclerosis, a chronic autoimmune disease that affects the central nervous system. These therapies include disease-modifying treatments (DMTs), biologics, oral medications, and injectable therapies designed to reduce relapse rates, slow disease progression, and improve patient...
0 Comments ·0 Shares ·9 Views ·0 Reviews
Please log in to like, share and comment!